S 1723 United States Senate · 117th Congress

Budgeting for Opioid Addiction Treatment Act

Summary
Budgeting for Opioid Addiction Treatment Act This bill imposes an excise tax on the sale of any active opioid. The tax is equal to one cent per milligram so sold and it is imposed on the manufacturer, producer, or importer of the opioid. The term active opioid means any controlled substance that is opium, an opiate, or any derivative thereof. The bill provides block grants for substance abuse treatment programs. The Department of Health and Human Services must report on the impact of this bill on (1) the retail cost of active opioids; (2) patient access to such opioids, particularly cancer and hospice patients; and (3) the use of tax revenues to improve substance abuse treatment efforts. The report must also make suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.
Bill status in committee 1 of 4 stages cleared
Introduction
May 2021
Committee Review
Floor Vote
President
Introduced May 20, 2021 Last action May 20, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
May 20, 2021
Committee
Read twice and referred to the Committee on Finance.
upper
May 20, 2021
Introduced
Introduced in Senate
upper
1 primary · 10 co-sponsors

Sponsors